Key result
Severe OSA is linked to a ~119% higher risk of type 2 diabetes.
Why the study?
Obstructive sleep apnea might induce type 2 diabetes mellitus, prompting exploration of the dose-response relationship between OSA and T2DM.
Does the severity of obstructive sleep apnea (OSA) increase the risk of type 2 diabetes mellitus (T2DM)?
Meta-Analysis
Does the severity of obstructive sleep apnea (OSA) increase the risk of type 2 diabetes mellitus (T2DM)?
Effect estimate: OR 2.19 (95% CI 1.30-3.68)
p-value: p=<0.05
There is a dose-response relationship between the severity of obstructive sleep apnea and the risk of developing type 2 diabetes mellitus.
OSA severity may refine T2DM risk stratification; leaves open whether treating OSA prevents diabetes.
Aim/Introduction. Obstructive sleep apnea (OSA) is a sleep-related breathing disorder that is characterized by repeated episodes of upper airway occlusion during sleep. The patients with OSA suffered from comprehensive oxidative stress in all systems. OSA might induce type 2 diabetes mellitus (T2DM), a kind of metabolism disorder. In this passage, we are exploring the dose-response relationship between OSA and T2DM. Materials and Methods. We screened four databases (PubMed, Embase, Cochran Library, and CNKI) for the observational studies about the OSA and T2DM. Studies were collected from database establishment to October 2020. We performed a traditional subgroup meta-analysis. What is more, linear and spline dose-response models were applied to assess the association between apnea-hypopnea index (AHI), an indicator to evaluate the severity of OSA, and the risk of T2DM. Review Manager, version 5.3, software and Stata 16.0 were used for the analysis. Result. Seven observational studies were included in the research. We excluded a study in the conventional meta-analysis. In the subgroup analysis, mild-dose AHI increased the risk of T2DM (odds ratio = 1.23, 95% confidence interval = 1.06–1.41, <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>P</a:mi> </a:math> < 0.05). Moderate-dose AHI increased the risk of T2DM with a higher odds ratio (OR = 1.35, 95% CI = 1.13–1.61, <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mi>P</c:mi> </c:math> < 0.05). Moderate-to-severe-dose AHI increased the risk of T2DM with a higher odds ratio (OR = 2.14, 95% CI = 1.72–2.67, <e:math xmlns:e="http://www.w3.org/1998/Math/MathML" id="M3"> <e:mi>P</e:mi> </e:math> < 0.05). Severe-dose AHI increased the risk of T2DM with a higher odds ratio (OR = 2.19 95% CI = 1.30–3.68, <g:math xmlns:g="http://www.w3.org/1998/Math/MathML" id="M4"> <g:mi>P</g:mi> </g:math> < 0.05). Furthermore, the spline and linear dose-response meta-analysis results revealed that the risk of T2DM increased with increasing AHI values. Conclusion. Through the dose-response meta-analysis, we found a potential dose-response relationship existed between the severity of OSA and the risk of T2DM. This relationship in our passage should be considered in the prevention of T2DM in the future.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2021) conducted a meta-analysis in Obstructive sleep apnea and Type 2 Diabetes Mellitus. Obstructive sleep apnea was evaluated on Risk of Type 2 Diabetes Mellitus (OR 2.19, 95% CI 1.30-3.68, p=<0.05). Increasing severity of obstructive sleep apnea was associated with a dose-dependent increase in the risk of type 2 diabetes mellitus (severe AHI OR 2.19; 95% CI 1.30-3.68; P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: